Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Jul-13 4:14 PM View:  | Deitcher Steven R President & CEO Director | Talon Therapeutics, Inc. (TLON) | 17-Jul-13 | Disposition | 184,192 | -- | -- | (100%) 184.19K to 0 | |
| 18-Jul-13 4:48 PM View: | Rosenberg Leon E Director | Talon Therapeutics, Inc. (TLON) | 17-Jul-13 | Disposition | 250 | -- | -- | (50%) 0.5K to 0.25K | |
| 18-Jul-13 4:44 PM View: | Maier Paul V Director | Talon Therapeutics, Inc. (TLON) | 17-Jul-13 | Disposition | 1,750 | -- | -- | (100%) 1.75K to 0 | |
| 18-Jul-13 5:09 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 16-Jul-13 | Sale | 27,293,500 | $0.06 | $1,531,170.00 | (100%) 27.29M to 0 | |
| 18-Jul-13 5:50 PM View: | Weatherman Elizabeth H Director | Talon Therapeutics, Inc. (TLON) | 16-Jul-13 | Conversion Duplicate | 152,330,000 | $0.50 | $76,523,200.00 | 234% 65.02M to 217.35M | |
| 18-Jul-13 5:47 PM View: | Warburg Pincus & Co Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 16-Jul-13 | Conversion | 152,330,000 | $0.50 | $76,523,200.00 | 234% 65.02M to 217.35M | |
| 18-Jul-13 5:50 PM View: | Weatherman Elizabeth H Director | Talon Therapeutics, Inc. (TLON) | 16-Jul-13 | Sale | 152,330,000 | $0.06 | $9,139,800.00 | (70%) 217.35M to 65.02M | |
| 18-Jul-13 5:09 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 16-Jul-13 | Conversion | 26,970,000 | $0.43 | $11,515,800.00 | 8335% 323.5K to 27.29M | |
| 18-Jul-13 5:47 PM View: | Warburg Pincus & Co Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 16-Jul-13 | Sale | 152,330,000 | $0.06 | $8,530,480.00 | (70%) 217.35M to 65.02M | |
| 09-Jul-12 7:07 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 05-Jul-12 | Market Sale | 540,000 | $1.22 | $658,800.00 | (63%) 863.56K to 323.56K | 67% |
| 03-Jul-12 5:24 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 03-Jul-12 | Market Sale | 550,752 | $1.33 | $732,500.00 | (39%) 1.41M to 863.56K | 70% |
| 03-Jul-12 5:24 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 02-Jul-12 | Market Sale | 166,527 | $1.20 | $199,832.00 | (11%) 1.58M to 1.41M | 67% |
| 03-Jul-12 5:24 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 29-Jun-12 | Market Sale | 194,635 | $1.14 | $221,884.00 | (11%) 1.78M to 1.58M | 65% |
| 28-Jun-12 7:02 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 28-Jun-12 | Market Sale | 219,800 | $1.07 | $235,186.00 | (11%) 2.0M to 1.78M | 62% |
| 28-Jun-12 7:02 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 27-Jun-12 | Market Sale | 116,256 | $1.00 | $116,256.00 | (6%) 2.11M to 2.0M | 60% |
| 28-Jun-12 7:02 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 26-Jun-12 | Market Sale | 62,317 | $0.98 | $61,070.70 | (3%) 2.17M to 2.11M | 59% |
| 07-May-12 8:41 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 03-May-12 | Market Sale | 231,100 | $0.99 | $228,138.00 | (10%) 2.4M to 2.17M | 59% |
| 23-Mar-12 5:43 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 21-Mar-12 | Market Sale | 115,000 | $1.05 | $120,750.00 | (5%) 2.52M to 2.4M | 61% |
| 14-Mar-12 9:01 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 14-Mar-12 | Market Sale | 35,526 | $1.01 | $35,881.30 | (1%) 2.56M to 2.52M | 60% |
| 14-Mar-12 9:01 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 13-Mar-12 | Market Sale | 18,500 | $1.04 | $19,240.00 | (< 1%) 2.57M to 2.56M | 61% |
| 14-Mar-12 9:01 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 12-Mar-12 | Market Sale | 123,180 | $1.11 | $136,730.00 | (5%) 2.7M to 2.57M | 63% |
| 12-Mar-12 11:06 AM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 09-Mar-12 | Market Sale | 153,000 | $1.20 | $183,600.00 | (5%) 2.85M to 2.7M | 66% |
| 12-Mar-12 11:06 AM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 08-Mar-12 | Market Sale | 55,000 | $1.04 | $57,200.00 | (2%) 2.91M to 2.85M | 61% |
| 12-Mar-12 11:06 AM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 07-Mar-12 | Market Sale | 21,000 | $0.99 | $20,790.00 | (< 1%) 2.93M to 2.91M | 59% |
| 08-Feb-12 8:46 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 06-Feb-12 | Market Sale | 25,000 | $0.98 | $24,500.00 | (< 1%) 2.95M to 2.93M | 59% |
| 28-Sep-11 7:01 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 26-Sep-11 | Market Sale (Planned) | 7,500 | $1.00 | $7,500.00 | (< 1%) 2.96M to 2.95M | 61% |
| 26-Sep-11 6:22 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 22-Sep-11 | Market Sale (Planned) | 11,493 | $0.98 | $11,263.10 | (< 1%) 2.97M to 2.96M | 60% |
| 21-Sep-11 9:07 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 20-Sep-11 | Market Sale (Planned) | 25,499 | $1.00 | $25,499.00 | (< 1%) 3.0M to 2.97M | 61% |
| 21-Sep-11 9:07 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 19-Sep-11 | Market Sale (Planned) | 33,000 | $1.05 | $34,650.00 | (1%) 3.03M to 3.0M | 62% |
| 02-Sep-11 9:33 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 31-Aug-11 | Market Sale (Planned) | 85,500 | $0.97 | $82,935.00 | (3%) 3.11M to 3.03M | 60% |
| 18-Jul-11 9:52 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 14-Jul-11 | Market Sale (Planned) | 13,200 | $0.99 | $13,068.00 | (< 1%) 3.13M to 3.11M | 60% |
| 27-Jun-11 7:41 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 27-Jun-11 | Market Sale (Planned) | 15,500 | $1.06 | $16,430.00 | (< 1%) 3.14M to 3.13M | 63% |
| 27-Jun-11 7:41 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 24-Jun-11 | Market Sale (Planned) | 88,793 | $1.07 | $95,008.50 | (3%) 3.23M to 3.14M | 63% |
| 27-Jun-11 7:41 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 23-Jun-11 | Market Sale (Planned) | 141,207 | $1.01 | $142,212.00 | (4%) 3.37M to 3.23M | 61% |
| 15-Jun-11 9:26 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 13-Jun-11 | Market Sale | 33,181 | $1.02 | $33,844.60 | (< 1%) 3.41M to 3.37M | 61% |
| 07-Jun-11 8:35 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 07-Jun-11 | Private Sale | 55,000 | $1.03 | $56,650.00 | (2%) 3.46M to 3.41M | 6% |
| 07-Jun-11 8:35 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 06-Jun-11 | Market Sale | 43,000 | $1.02 | $43,860.00 | (1%) 3.5M to 3.46M | 61% |
| 07-Jun-11 8:35 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 03-Jun-11 | Market Sale | 9,130 | $1.01 | $9,221.30 | (< 1%) 3.51M to 3.5M | 61% |
| 31-May-11 9:00 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 31-May-11 | Market Sale | 26,292 | $0.99 | $26,029.10 | (< 1%) 3.54M to 3.51M | 60% |
| 31-May-11 9:00 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 27-May-11 | Market Sale | 44,700 | $0.99 | $44,253.00 | (1%) 3.58M to 3.54M | 60% |
| 31-May-11 9:00 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 26-May-11 | Market Sale | 121,880 | $1.01 | $123,099.00 | (3%) 3.71M to 3.58M | 61% |
| 24-May-11 8:55 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 24-May-11 | Market Sale | 281,001 | $1.00 | $281,001.00 | (7%) 3.99M to 3.71M | 60% |
| 24-May-11 8:55 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 23-May-11 | Market Sale | 16,207 | $1.00 | $16,207.00 | (< 1%) 4.0M to 3.99M | 60% |
| 24-May-11 8:55 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 20-May-11 | Market Sale | 76,395 | $0.99 | $75,905.00 | (2%) 4.08M to 4.0M | 60% |
| 19-May-11 8:34 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 19-May-11 | Market Sale | 52,039 | $1.11 | $57,763.30 | (1%) 4.13M to 4.08M | 64% |
| 19-May-11 8:34 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 18-May-11 | Market Sale | 76,759 | $1.11 | $85,202.50 | (2%) 4.21M to 4.13M | 64% |
| 19-May-11 8:34 PM View: | Flynn James E Director 10% Owner | Talon Therapeutics, Inc. (TLON) | 17-May-11 | Market Sale | 168,822 | $1.12 | $189,081.00 | (4%) 4.38M to 4.21M | 65% |
| 04-Feb-11 5:15 PM View: | Deitcher Steven R President & CEO Director | Talon Therapeutics, Inc. (TLON) | 02-Feb-11 | Grant | 179,192 | -- | -- | 3584% 5.0K to 184.19K | |
| 30-Jan-09 10:00 PM View: | Hagey Anne E VP, Chief Medical Officer | Talon Therapeutics, Inc. (TLON) | 13-Aug-08 | Gift | 100 | -- | -- | (100%) 100 to 0 | |
| 21-Aug-08 4:19 PM View: | Hagey Anne E VP, Chief Medical Officer | Talon Therapeutics, Inc. (TLON) | 08-Aug-08 | Acquisition (small) | 100 | $0.62 | $61.99 | 100% 0 to 100 |
